Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

kelly smith

- PMLiVE

Astellas adds to regenerative medicine unit with Ocata buy

Willpay around $379m for the cell therapy specialist

- PMLiVE

FDA approves Exelixis/Genentech’s melanoma combo Cotellic

Willprovide the first direct competition to Novartis' Mekinist in the US

Lucid’s motivation to make a difference in medical education drives everything they do

Changing lives with medical education

Lucid Group Communications Limited

WAE appoints new non-executive director

Tracey Barr to helpdrive growth in healthcare sector

Teva Pharma logo

TEVA’s tardive dyskinesia drug wins FDA breakthrough status

SD-809 to be given development incentives

Tragedy of the commons

Evolution suggests we need to be altruistic to our rivals

- PMLiVE

Amgen’s biosimilar shows clinical equivalence with Humira

ABP 501 as effective as AbbVie's blockbuster in phase III rheumatoid arthritis trial

- PMLiVE

GSK and AZ drugs impress in lupus trials

Raises hope for better treatment for debilitating disease

- PMLiVE

At long last, Merck gets FDA panel backing for Bridion

Unanimous vote in favour of drug suggest it is back on course for approval

- PMLiVE

Novartis curates interactive history of medicine exhibition

Beautiful Medicine highlights nature's role in the past and future ofdevelopment

- PMLiVE

Orrin Pollard joins behavioural change agency Hamell

Theformer DDB Remedy chairman takes up an executive creative director role

- PMLiVE

Boehringer appoints new chairman of the board

Hubertus vonBaumbach will succeed Andreas Barner

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links